NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
Marine Corps, Coast Guard Lay Groundwork for AI Operations
Service officials are improving data and network infrastructure to support AI-enabled operations and information sharing.
2m read -
AI, Zero Trust Drive Geospatial Intelligence Modernization
NGA CIO Mark Chatelain discusses how zero trust, cloud modernization and AI are strengthening cyber resilience and accelerating geospatial intelligence.
8m watch -
DIA Accelerates AI Adoption, IT Modernization
Deputy DIA CIO Marc Zuccola discusses AI adoption, IT modernization and industry collaboration to strengthen cybersecurity.
9m watch -
Readiness Lessons From CIA's First Chief Wellbeing Officer
Former CIA Chief Wellbeing Officer Jennifer Posa discussed why workforce wellbeing is a strategic driver of mission success.
42m watch
